Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Gets Second Order for Sequencing System; Inks Alliance with Uppsala University

NEW YORK (GenomeWeb News) – Helicos BioSciences said today that it has received an order for its Helicos Genetic Analysis System from an unnamed cancer research center in the US.

The order is the second for the firm’s flagship DNA sequencing platform since its launch earlier this year. The first customer, genomics services firm Expression Analysis, purchased a Helicos GAS in February.

Helicos said today that the cancer center will use the system in a research program involving cancer stem cell biology.

Further terms of the purchase were not disclosed.

In a separate announcement, Helicos said that it had signed a scientific collaboration with Sweden’s Uppsala University, under which researchers at the university will use Helicos’ single molecule sequencing technology to study changes in the cell nucleus that occur in the presence of growth factors.

Helicos said the researchers would study changes in the structure of the protein-DNA complexes that make up chromosomes and how they interact with transcription factors that bind DNA, which may “provide a more complete understanding of how structural features of the genome affect gene expression.”

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.